NDC00641-6127-25 — MORPHINE SULFATE INJECTION

✓ Government record, cited

— · COMPONENT

PRODUCT OVERVIEW

NDC00641-6127-25: MORPHINE SULFATE INJECTION.

The MORPHINE SULFATE INJECTION is a the manufacturer industrial component. Key specifications include special_features: PROTECT FROM LIGHT;STORE AT 15-30 DEG C DEGC, features_provided: STERILE, primary_container_type: VIAL, supplementary_features: CONTROLLED SUBSTANCE SCHEDULE II; HIGH ABUSE POTENTIAL WITH SEVERE DEPENDENCE LIABILITY, protective_storage_feature: SUBJECT TO DAMAGE BY FREEZING AND SECURITY STORAGE, pharmaceutical_vehicle_type: AQUEOUS. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-483-0274, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS

NDC00641-6127-25

NSN: 6505-01-483-0274
FSC: 6505 — Drugs and Biologicals
CAGE: 32655 — HIKMA PHARMACEUTICALS USA INC. (USA)

SPECIFICATIONS

special_features	PROTECT FROM LIGHT;STORE AT 15-30 DEG C DEGC
features_provided	STERILE
primary_container_type	VIAL
supplementary_features	CONTROLLED SUBSTANCE SCHEDULE II; HIGH ABUSE POTENTIAL WITH SEVERE DEPENDENCE LIABILITY
protective_storage_feature	SUBJECT TO DAMAGE BY FREEZING AND SECURITY STORAGE
pharmaceutical_vehicle_type	AQUEOUS
medical_designation_and_grade	UNITED STATES PHARMACOPEIA
total_primary_container_quantity	25
primary_container_content_quantity	1.000 MILLILITERS
active_medicament_medicinal_strength	10.000 MILLIGRAMS MORPHINE SULFATE PER MILLILITER
part_name_assigned_by_controlling_agency	MORPHINE SULFATE INJECTION USP 10MG/ML 1ML VIAL 25S
NSN	6505-01-483-0274

COMPONENT DIAGRAM

KEY FEATURES

•

PRIMARY CONTAINER CONTENT QUANTITY: 1.000 MILLILITERS

•

SUPPLEMENTARY FEATURES: CONTROLLED SUBSTANCE SCHEDULE II; HIGH ABUSE POTENTIAL WITH SEVERE DEPENDENCE LIABILITY

•

MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA

•

FEATURES PROVIDED: STERILE

•

PRIMARY CONTAINER TYPE: VIAL

•

PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING AND SECURITY STORAGE

TECHNICAL CHARACTERISTICS

PRIMARY CONTAINER CONTENT QUANTITY	1.000 MILLILITERS
SUPPLEMENTARY FEATURES	CONTROLLED SUBSTANCE SCHEDULE II; HIGH ABUSE POTENTIAL WITH SEVERE DEPENDENCE LIABILITY
MEDICAL DESIGNATION AND GRADE	UNITED STATES PHARMACOPEIA
FEATURES PROVIDED	STERILE
PRIMARY CONTAINER TYPE	VIAL
SPECIAL FEATURES	PROTECT FROM LIGHT;STORE AT 15-30 DEG C DEGC
PROTECTIVE STORAGE FEATURE	SUBJECT TO DAMAGE BY FREEZING AND SECURITY STORAGE
PART NAME ASSIGNED BY CONTROLLING AGENCY	MORPHINE SULFATE INJECTION USP 10MG/ML 1ML VIAL 25S
PHARMACEUTICAL VEHICLE TYPE	AQUEOUS
ACTIVE MEDICAMENT MEDICINAL STRENGTH	10.000 MILLIGRAMS MORPHINE SULFATE PER MILLILITER

SUBSTITUTES & CROSS-REFERENCES 1

01-0114Reference document

Same NSN cross-reference

Reference document — Secondary reference

LIFECYCLE

NSN statusActive· U.S. Government catalog

Shelf-life managedNo demilitarization required

Ready to buy NDC00641-6127-25?

Compare prices from verified sellers on eBay

Buy on eBay →

As an eBay Partner, PartsTable may earn a commission. Your price is not affected.

FREQUENTLY ASKED QUESTIONS

What is NDC00641-6127-25?

NDC00641-6127-25 is a MORPHINE SULFATE INJECTION.

What parts can replace NDC00641-6127-25?

There is 1 known substitute for NDC00641-6127-25: 01-0114. Substitute compatibility should be verified for your specific system.

What is the NSN for NDC00641-6127-25?

NDC00641-6127-25 is cataloged in the U.S. Government catalog under NSN 6505-01-483-0274. This indicates validated use in U.S. government and defense supply chains.

Community Feedback

NDC00641-6127-25 — MORPHINE SULFATE INJECTION

Request a Quote — NDC00641-6127-25